iGMDRD551
Canonical SMILES: CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5
InChI: InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)
InChI Key: PHXJVRSECIGDHY-UHFFFAOYSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
---|---|---|---|---|---|
Standard NamePonatinib CHEMBLCHEMBL1171837 CHEMBL2105708 Pubchem CID24826800 DRUGBANK IDDB08901 Drug StatusAlone Drug TypeSmall Molecule |
Drug Class:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsAzolesBCRP/ABCG2 InhibitorsBCRP/ABCG2 SubstratesCytochrome P-450 Enzyme InhibitorsEnzyme InhibitorsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunosuppressive AgentsKinase InhibitorMyelosuppressive AgentsP-glycoprotein/ABCB1 InhibitorsP-glycoprotein/ABCB1 SubstratesProtein Kinase InhibitorsDrug Targets:
ABL1 (P00519)BCR (P11274)KIT (P10721)RET (P07949)TEK (Q02763)FLT3 (P36888)FGFR1 (P11362)FGFR2 (P21802)FGFR3 (P22607)FGFR4 (P22455)LCK (P06239)SRC (P12931)LYN (P07948)KDR (P35968)PDGFRA (P16234)Drug Pathways:
RTK signalingDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Ponatinib
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |